| Literature DB >> 33544431 |
Prakhar Jaiswal1, Swati Sharma2, Arvind Pratap1, Mumtaz Ansari1, Vijay K Shukla1, Somprakas Basu3, Tuhina Banerjee2.
Abstract
Fistula-in-ano though not a life-threatening condition, yet its symptoms often significantly impact patients' social, intimate, and work lives. There is an established role of bacterial microflora in acute infections. However, we proposed that biofilm-forming organisms might be present in the microflora of anal fistula of prolonged duration. This aspect has rarely been studied earlier. Therefore, the study describes the microbiology of anal fistula and the biofilm-forming capacity of the isolated organisms. A total of 30 patients were included in the study as per the criteria. Anal fistula tissue sample, tissue fluid, and blood samples were collected from each individual. The collected specimens were detected for the presence of aerobic and anaerobic microflora through standard microbiological method and polymerase chain reaction. Furthermore, the role of biofilm formation by microtitre plate assay and serum matrix metalloproteinases-9 was also studied. The result showed significant predominance of gut-derived microflora with high-to-moderate biofilm-producing ability in anal fistulas of prolonged duration. The study emphasises the presence of biofilm-forming bacteria in chronic, non-healing fistula.Entities:
Keywords: E. coli; MMP9; anaerobic; microtiter plate assay; persistent
Year: 2021 PMID: 33544431 PMCID: PMC8273591 DOI: 10.1111/iwj.13551
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.315
Microflora identified in anal fistula samples
| Microbial burden | Microorganisms | N (%) |
|---|---|---|
| Monomicrobial (n = 15) |
| 11 (37) |
|
| 2 (7) | |
|
| 1 (3) | |
|
| 1 (3) | |
| Polymicrobial (n = 14) |
| 1 (3) |
|
| 1 (3) | |
|
| 2 (7) | |
|
| 1 (3) | |
|
| 1 (3) | |
|
| 1 (3) | |
|
| 1 (3) | |
|
| 3 (10) | |
|
| 1 (3) | |
|
| 1 (3) | |
|
| 1 (3) |
FIGURE 1Microtitre plate assay for detection of biofilm formation in microorganisms
FIGURE 2Degree of biofilm formation among the gut‐derived bacteria
Bacterial biofilm formation in comparison with duration of illness
| Total duration of illness | |||
|---|---|---|---|
| Biofilm formation | ≤6 months (n = 15) | >6 months (n = 15) |
|
| All cases | |||
| Low | 7 | 2 | .05* |
| Medium/high | 7 | 12 | |
|
| |||
| Low | 4 | 0 | .01* |
| Medium/high | 2 | 16 |
Note: *P value < .05.
Comparison of mean serum MMP9 with various parameters
| Parameters | Serum MMP9 value (mean ± SD) |
|
|---|---|---|
| Duration of fistula | ||
| ≤6 months | 2773.54 ± 1293.19 | .34 |
| >6 months | 2367.85 ± 974.19 | |
| Nature of fistula tract | ||
| Single non‐branching linear | 2329.52 ± 912.66 | .29 |
| Single curved | 3484.94 ± 1753.53 | |
| Single low anal | 2860.53 ± 1485.33 | |
| Irregular branching | 2319.16 ± 719.23 | |
| Type of fistula | ||
| Intersphincteric | 2639.27 ± 1294.55 | .71 |
| Transsphincteric | 2159.26 ± 996.99 | |
| Suprasphincteric | 2166.49 ± 756.38 | |
| Extrasphincteric | 2961.39 ± 670.11 | |
| Microbial growth | ||
| Present | 2540.20 ± 1175.37 | .59 |
| Absent | 2997.68 ± 492.74 |